Drug addiction is a complex, chronic relapsing illness characterized by compulsive drug use. It is a serious public health issue that affects the individual, family, and communities at large. It is one of the most difficult forms of addiction to overcome and is associated with a wide variety of short-term and long-term physical and mental health consequences. Drug addiction is a form of substance-use disorder which occurs when a person develops an intense craving and compulsion to take drugs. It is a progressive illness which makes it difficult to stop using drugs, even when the individual knows the negative consequences of their drug use. Drug addiction also changes the structure and functioning of the brain affecting psychology and behaviour. It is a complex chronic illness, with social, genetic, and environmental determinants. Once an individual becomes addicted to drugs, their body starts to develop a tolerance to the drug, meaning they need higher amounts over time to produce the same effect. The individual may also experience severe physical and psychological withdrawal symptoms, when the drug is stopped abruptly, making it hard to maintain abstinence from drugs. Treatment for drug addiction is an essential part of recovery. Medications such as methadone or buprenorphine, as well as comprehensive behavioral therapy, have been shown to be effective in treating drug addiction. Treatment should focus on the individual, not just their drug abuse. Treatment should be tailored to the individual needs, addressing the motivations for drug use and addressing the psychological and social issues associated with substance use. Life-long recovery from drug addiction is possible, but is dependent on the individual's commitment to making long-term changes to their lifestyle and behavior.
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : ADNP regulates cortical development: Mechanism of ADNP syndrome/autism
Kazuhito Toyooka, Drexel University College of Medicine, United States
Title : Mild cognitive impairment (MCI) in Parkinson’s disease: Prevalence given MDS criteria
Cay Anderson Hanley, iPACES, United States
Title : Modeling early neurologic trajectories after elevated leg positioning (ELP): A secondary analysis of the LEG-UP randomized feasibility study
Kayode Ahmed, The University of Texas MD Anderson Cancer Center, United States
Title : Neuro-exergaming for non-verbal autism spectrum: A case study of neuropsychological function after 15 sessions of pedal-n-play iPACES
Cay Anderson Hanley, iPACES, United States
Title : Prescribing joy: The importance of integrating memory cafes into dementia care
Saul Beaumont, Massachusetts Advisory Council on Alzheimer's Disease and All Other Dementias, United States